Behavioral benefits of GSK-3β inhibition and state-dependent microtubule signatures in the Fmr1-KO mouse
Glycogen-synthase-kinase-3β (GSK-3β) and microtubule dynamics are implicated in Fragile X syndrome (FXS). We examined behaviors and hippocampal <i>α</i>-tubulin post-translational modifications (PTMs) in <i>Fmr1</i>-KO male mice without and with chronic administration of the GSK-3β inhibitors SB216763 (30 mg/kg, i.p.) and AF3581 (10 mg/kg, i.p.). <i>Fmr1</i>-KO male mice and wild-type (WT) were evaluated in the open field, marble-burying, elevated-plus-maze (EPM), novel-object-recognition (NOR) and three-chamber sociability test (3-CST); acetylated <i>α</i>-tubulin (Acet/Total-Tub) and tyrosinated/detyrosinated <i>α</i>-tubulin (Tyr/Glu-Tub) ratios were then analyzed. <i>Fmr1</i>-KO male showed hyperactivity, excessive marble burying and impaired NOR; Acet/Total-Tub was elevated and Tyr/Glu-Tub reduced vs. WT, indicating reduced microtubule dynamics. In a mixed-sex cohort bred female WT displayed lower Acet/Total-Tub and increased Tyr/Glu-Tub vs. male WT. The <i>Fmr1</i>-KO-associated decrease in Tyr/Glu-Tub was consistent across sexes. FMRP and synaptic markers were also analyzed in this cohort, spinophilin was found increased in both male and female <i>Fmr</i>1-KO. <i>Fmr1</i>-heterozygous females showed no molecular alterations, supporting the protective role of FMRP. <i>Fmr1</i>-KO male mice received vehicle or GSK-3β inhibitors and were tested in behavioral assays followed by <i>α</i>-tubulin PTMs analysis. Daily vehicle injections appeared to abolish baseline differences in hyperactivity, marble burying and <i>α</i>-tubulin PTMs. Under these conditions both inhibitors reduced marble burying. SB216763 normalized social discrimination in 3-CST, while AF3581 only produced a non-significant positive trend. Neither compound altered <i>α</i>-tubulin PTMs. These results show that GSK-3β inhibition has anti-perseverative and pro-social effects in <i>Fmr1</i>-KO male mice. However, behavioral and molecular endpoints, such as <i>α</i>-tubulin PTMs, appear to be sensitive to both genetic background and experimental procedures.
Authors
- Aimée Freeburn
- Claudio Milanese
- John Kealy (ORCID: https://orcid.org/0000-0002-0503-4379)
- Charlotte K. Callaghan (ORCID: https://orcid.org/0000-0002-2136-9005)
- Chris Greene (ORCID: https://orcid.org/0000-0003-4192-9433)
- Massimiliano Bianchi (ORCID: https://orcid.org/0000-0003-1136-1816)
- Beatrice Garrone (ORCID: https://orcid.org/0000-0002-8318-2975)
- Aoife M. Thornton (ORCID: https://orcid.org/0000-0003-0012-0515)
Institutions
- Trinity College Dublin (IE)
- Voysis (Ireland) (IE)
- Angelini Pharma (Italy) (IT)
Publication Details
- Journal
- Frontiers in Neuroscience
- Published
- 2025-10-02
- DOI
- https://doi.org/10.3389/fnins.2025.1643439
- Primary Topic
- Genetics and Neurodevelopmental Disorders
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Angelini Pharma